Jupiter Neurosciences Stock Quote JUNS - Stock Price, News, Charts, Message Board, Trades

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Premium

Current Price

3.64

Bid

3.60

Ask

3.64

Volume

19,049

0.00 Day's Range 0.00

3.00 52 Week Range 19.51

Market Cap

120.498M

Previous Close

3.58

Open

Last Trade

3.61

Last Trade Time

04:35:42

Financial Volume

VWAP

Average Volume (3m)

690,166

Shares Outstanding

33,103,860

Dividend Yield

PE Ratio

-24.78

Earnings Per Share (EPS)

-0.14

Revenue

Net Profit

-4.78M

Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL¿ , has many potential indications of use for rare diseases, which of we pri... Jupiter Neurosciences is a clinical stage research and development pharmaceutical company. The Company has developed a unique resveratrol platform product targeting treatment of neuro-inflammation. The product, called JOTROL¿ , has many potential indications of use for rare diseases, which of we primarily are targeting Mucopolysaccharidoses Type 1, Friedreichs Ataxia, and MELAS as well as ALS which is in an early development stage. In the larger disease areas, we are primarily targeting Mild Cognitive Impairment/early Alzheimers disease with TBI/concussions and Covid-19 in early development stages. Based on available scientific literature, we believe that JOTROL¿ is the first and only resveratrol product in the world that delivers a therapeutically effective dose of resveratrol in the blood stream without causing gastrointestinal side effects. Show more

Sector

Pharmaceutical Preparations

Industry

Pharmaceutical Preparations

Website

www.jupiterneurosciences.com

Headquarters

Wilmington, Delaware, USA

Founded

Jupiter Neurosciences Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker JUNS. The last closing price for Jupiter Neurosciences was $3.58. Over the last year, Jupiter Neurosciences shares have traded in a share price range of $ 3.00 to $ 19.51.

Jupiter Neurosciences currently has 33,103,860 shares outstanding. The market capitalization of Jupiter Neurosciences is $118.51 million. Jupiter Neurosciences has a price to earnings ratio (PE ratio) of -24.78.

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	-1.45	-28.4872298625	5.09	5.7743	3	2089156	3.73737559	CS
4	-8.24	-69.3602693603	11.88	12.5	3	882443	5.85102688	CS
12	-0.36	-9	4	19.51	3	690166	7.31169902	CS
26	-0.36	-9	4	19.51	3	690166	7.31169902	CS
52	-0.36	-9	4	19.51	3	690166	7.31169902	CS
156	-0.36	-9	4	19.51	3	690166	7.31169902	CS
260	-0.36	-9	4	19.51	3	690166	7.31169902	CS

JUNS - Frequently Asked Questions (FAQ)

What is the current Jupiter Neurosciences share price?

The current share price of Jupiter Neurosciences is $ 3.64

How many Jupiter Neurosciences shares are in issue?

Jupiter Neurosciences has 33,103,860 shares in issue

What is the market cap of Jupiter Neurosciences?

The market capitalisation of Jupiter Neurosciences is USD 118.51M

What is the 1 year trading range for Jupiter Neurosciences share price?

Jupiter Neurosciences has traded in the range of $ 3.00 to $ 19.51 during the past year

What is the PE ratio of Jupiter Neurosciences?

The price to earnings ratio of Jupiter Neurosciences is -24.78

What is the reporting currency for Jupiter Neurosciences?

Jupiter Neurosciences reports financial results in USD

What is the latest annual profit for Jupiter Neurosciences?

The latest annual profit of Jupiter Neurosciences is USD -4.78M

What is the registered address of Jupiter Neurosciences?

The registered address for Jupiter Neurosciences is 1209 ORANGE STREET, WILMINGTON, DELAWARE, 19801

What is the Jupiter Neurosciences website address?

The website address for Jupiter Neurosciences is www.jupiterneurosciences.com

Which industry sector does Jupiter Neurosciences operate in?

Jupiter Neurosciences operates in the PHARMACEUTICAL PREPARATIONS sector

Most Active
% Gainers
% Losers

Symbol	Price	Vol.
DGNXDiginex Ltd	18.21 (142.80%)	319.32k
FSEAFirst Seacoast Bancorp Inc	$ 15.90 (59.00%)	6
BBGIBeasley Broadcast Group Inc	$ 13.31 (58.45%)	14
FBNCFirst Bancorp	$ 67.00 (52.62%)	205
CFSBCFSB Bancorp Inc	$ 11.25 (50.00%)	40
CVBFCVB Financial Corporation	$ 11.00 (-46.83%)	203
CPBICentral Plains Bancshares Inc	$ 10.01 (-31.67%)	7
DCOMDime Community Bancshares Inc	$ 22.00 (-30.71%)	200
TSBKTimberland Bancorp Inc	$ 21.01 (-27.63%)	12
XNCRXencor Inc	$ 15.01 (-27.38%)	1
KOPNKopin Corporation	$ 2.14 (45.58%)	7.43M
HEPAHepion Pharmaceuticals Inc	$ 0.1599 (18.44%)	4.39M
TNXPTonix Pharmaceuticals Holding Corporation	$ 0.3289 (3.10%)	3.93M
ASSTAsset Entities Inc	$ 1.64 (20.59%)	3.4M
SHViShares Short Treasury Bond ETF	$ 110.38 (0.02%)	3.37M